Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Lai

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|May 1, 2010
Do we need to change our national organ donation policy?Michelle Lai
Hepatology (Baltimore, Md.)|May 21, 2015
Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?Michelle Lai
Digestive Diseases and Sciences|February 9, 2019
How the "Opt-In" Option Optimizes Organ Donation RatesGhideon Ezaz, Michelle Lai
Hepatology (Baltimore, Md.)|May 29, 2019
Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver DiseaseJody Dushay, Michelle Lai
JAMA Ophthalmology|October 14, 2016
Sudden Bilateral ProptosisMichelle Lai, Romesh Angunawela
Alimentary Pharmacology & Therapeutics|November 30, 2018
Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patientsRajab Idriss, Michelle Lai
Clinics in Liver Disease|July 20, 2010
Chronic hepatitis B: past, present, and futureMichelle Lai, Yun-Fan Liaw
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2019
Pediatricians underestimate parent receptiveness to early peanut introductionMichelle Lai, Scott H Sicherer
Proceedings (Baylor University. Medical Center)|April 2, 2014
Factors affecting adherence to a quality improvement checklist on an inpatient hepatology serviceElliot B Tapper, Michelle Lai
Frontline Gastroenterology|November 5, 2019
NAFLD: a multisystem disease that requires a multidisciplinary approachChristopher J Danford, Michelle Lai
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|May 1, 2010
Do we need to change our national organ donation policy?Michelle Lai
Hepatology (Baltimore, Md.)|May 21, 2015
Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?Michelle Lai
Digestive Diseases and Sciences|February 9, 2019
How the "Opt-In" Option Optimizes Organ Donation RatesGhideon Ezaz, Michelle Lai
Hepatology (Baltimore, Md.)|May 29, 2019
Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver DiseaseJody Dushay, Michelle Lai
JAMA Ophthalmology|October 14, 2016
Sudden Bilateral ProptosisMichelle Lai, Romesh Angunawela
Alimentary Pharmacology & Therapeutics|November 30, 2018
Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patientsRajab Idriss, Michelle Lai
Clinics in Liver Disease|July 20, 2010
Chronic hepatitis B: past, present, and futureMichelle Lai, Yun-Fan Liaw
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2019
Pediatricians underestimate parent receptiveness to early peanut introductionMichelle Lai, Scott H Sicherer
Proceedings (Baylor University. Medical Center)|April 2, 2014
Factors affecting adherence to a quality improvement checklist on an inpatient hepatology serviceElliot B Tapper, Michelle Lai
Frontline Gastroenterology|November 5, 2019
NAFLD: a multisystem disease that requires a multidisciplinary approachChristopher J Danford, Michelle Lai
Pageof 16